We are live on ! Find out more
CCM

Cadian Capital Management Portfolio holdings

AUM $1.32B
1-Year Est. Return 4.19%
This Fund
S&P 500
This Quarter Est. Return
+12.28%
1 Year Est. Return
+4.19%
3 Year Est. Return
+19.53%
5 Year Est. Return
+29.99%
10 Year Est. Return
+331.01%
AUM
$2.09B
AUM Growth
+$211M
Cap. Flow
+$27.2M
Cap. Flow %
1.3%
Top 10 Hldgs %
55.61%
Holding
57
New
14
Increased
10
Reduced
19
Closed
13

Top Sells

Rank Stock Value
1
EXPE icon
Expedia Group
EXPE
+$76.2M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$41.9M
3
BIIB icon
Biogen
BIIB
+$39.2M
4
CHTR icon
Charter Communications
CHTR
+$30.1M
5
PYPL icon
PayPal
PYPL
+$28.9M

Sector Composition

Rank Sector Weight
1 Technology 38.36%
2 Communication Services 22.43%
3 Healthcare 21.29%
4 Industrials 5.66%
5 Financials 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRNT
26
DELISTED
Verint Systems
VRNT
$27.1M 1.29%
1,224,309
+8,164
+0.7% +$159K
BABA icon
27
Alibaba
BABA
$272B
$26.8M 1.28%
+248,500
New +$25.3M
TLND
28
DELISTED
Talend S.A. American Depositary Shares
TLND
$24.5M 1.17%
+822,685
New +$21.1M
W icon
29
Wayfair
W
$13.7B
$24M 1.15%
592,897
-500,976
-46% -$19.8M
GOOGL icon
30
Alphabet (Google) Class A
GOOGL
$4.04T
$23.1M 1.1%
544,000
-140,000
-20% -$5.89M
GOOG icon
31
Alphabet (Google) Class C
GOOG
$4.02T
$21.3M 1.02%
513,000
-400,000
-44% -$16.4M
ELV icon
32
Elevance Health
ELV
$86.1B
$18.2M 0.87%
+110,000
New +$17.5M
KTWO
33
DELISTED
K2M Group Holdings, Inc
KTWO
$15.9M 0.76%
776,449
+50,000
+7% +$1.03M
COLL icon
34
Collegium Pharmaceutical
COLL
$760M
$13.7M 0.65%
1,357,748
+438,747
+48% +$6.52M
SRPT icon
35
Sarepta Therapeutics
SRPT
$2.32B
$10.2M 0.49%
345,811
-3,143
-0.9% -$97.3K
WK icon
36
Workiva
WK
$3.96B
$9.39M 0.45%
600,082
-261,205
-30% -$3.67M
SAGE
37
DELISTED
Sage Therapeutics
SAGE
$8.68M 0.42%
+122,125
New +$7.15M
BOX icon
38
Box
BOX
$4.73B
$7.09M 0.34%
+435,000
New +$7.35M
BPMC
39
DELISTED
Blueprint Medicines
BPMC
$6.99M 0.33%
+174,900
New +$6.26M
EXPE icon
40
Expedia Group
EXPE
$32.7B
$5.93M 0.28%
47,039
-623,911
-93% -$76.2M
APTI
41
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$5.88M 0.28%
+501,020
New +$7.25M
YHOO
42
DELISTED
Yahoo Inc
YHOO
$3.48M 0.17%
+75,000
New +$3.35M
RPXC
43
DELISTED
RPX Corporation
RPXC
$2.97M 0.14%
+247,530
New +$2.81M
DBVT
44
DBV Technologies
DBVT
$847M
$2.93M 0.14%
8,319
BIIB icon
45
Biogen
BIIB
$31.1B
-138,260
Closed -$39.2M
CHTR icon
46
Charter Communications
CHTR
$16B
-104,713
Closed -$30.1M
MSFT icon
47
Microsoft
MSFT
$3.65T
-430,000
Closed -$26.7M
ZBH icon
48
Zimmer Biomet
ZBH
$18B
-159,650
Closed -$16M
LGF.B
49
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
-76,193
Closed -$1.87M
LGF.A
50
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
-35,242
Closed -$948K

Similar funds

Cadian Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Cadian Capital Management held 57 positions worth $2.09B, up 11% from $1.88B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Cadian Capital Management's Q1 2017 filing shows 14 new, 10 increased, 19 reduced and 13 closed positions. Its largest new stake was Gigamon Inc.: 2,154,554 shares worth $76.6M. The largest sale was Expedia Group, an estimated $76.2M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 29% a quarter earlier, followed by Communication Services and Healthcare.

  • Cadian Capital Management's largest Q1 2017 buy was Gigamon Inc.: 2,154,554 shares worth $76.6M.
  • Cadian Capital Management added most to Palo Alto Networks in Q1 2017, an estimated $102M increase.
  • Cadian Capital Management's biggest Q1 2017 reduction was Expedia Group, cutting an estimated $76.2M.
  • Cadian Capital Management fully exited Biogen in Q1 2017, selling an estimated $39.2M.
  • Cadian Capital Management's ten largest holdings make up 56% of its $2.09B portfolio in Q1 2017.
  • Cadian Capital Management opened 14 new positions and closed 13 in Q1 2017.
  • Cadian Capital Management's portfolio value rose 11% quarter-over-quarter to $2.09B.

Based on Cadian Capital Management's 13F filing for Q1 2017, filed 12 May 2017.